ArticleJournal of inflammation research2025
Albumin and Gamma-Glutamyl Transferase as Biomarkers for Differentiating Systemic Juvenile Idiopathic Arthritis from Reactive Arthritis.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hybrid intelligent systems for liver disease prediction: a demographic-aware machine learning framework.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Systemic juvenile idiopathic arthritis (sJIA) and reactive arthritis (ReA) share overlapping clinical features, posing diagnostic challenges. Early differentiation is critical for treatment decisions but lacks reliable biomarkers. This study aims to identify simple clinical indicators and develop a clinical prediction model to distinguish sJIA from ReA. Methods: This study retrospectively included clinical data of 397 sJIA patients and 290 ReA patients who attended the Children's Hospital of Chongqing Medical University from 2016-2024. Key predictors were identified by ANOVA, chi-square tests, univariate logistic regression, multivariate logistic regression, and stepwise analysis. The diagnostic model was established and validated by performing ROC analysis. Furthermore, we additionally included data from 20 sJIA and 20 ReA patients from two other centers to validate the above results. Results: A total of 19 statistically different clinical indicators were identified by ANOVA and chi-square tests. These indicators were included in univariate and multivariate logistic regression analyses, lower albumin levels and significantly higher levels of gamma-glutamyl transferase (GGT) were found in sJIA patients compared to ReA in both the training and validation sets (p values were all < 0.05). In a stepwise analysis of age, gender, inflammatory cells (lymphocytes, monocytes) and inflammatory markers, it was found that albumin and GGT were still effective in differentiating between the two diseases. Clinical prediction models were developed using albumin and GGT, with AUCs of 0.842 (training) and 0.849 (validation), showing excellent diagnostic effect. These indicators also demonstrated good diagnostic efficacy in cohorts from two other centers. Conclusion: Albumin and GGT are important clinical indicators for differentiating sJIA from ReA. The albumin-GGT prediction model provides a simple, clinically feasible tool to reduce diagnostic uncertainty.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.